High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS

Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Neisseria adhesin A (NadA), and outer membrane vesic...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Sarah J. Tozer, Helen V. Smith, David M. Whiley, Ray Borrow, Giuseppe Boccadifuoco, Duccio Medini, Davide Serruto, Marzia Monica Giuliani, Maria Stella, Rosita De Paola, Alessandro Muzzi, Mariagrazia Pizza, Theo P. Sloots, Michael D. Nissen
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: Taylor & Francis Group 2021-09-01
Цуврал:Human Vaccines & Immunotherapeutics
Нөхцлүүд:
Онлайн хандалт:http://dx.doi.org/10.1080/21645515.2021.1904758